NAFDAC Approves Pfizer-Biotech COVID-19 Vaccine For Use In Nigeria
The National Agency for Food and Drug Administration and Control, NAFDAC, on Friday approved the use of Pfizer COVID-19 vaccine in Nigeria.
This is coming few months after it gave authorization for the use of the “Oxford-Astrazeneca jabs” in the country.
Announcing this at a press conference in Lagos, the Director-General of NAFDAC, Mojisola Adeyeye explained that the “Pfizer-Bio Tech vaccine” was for emergency use only.
She added that the vaccine can now be stored between -15 to-25 equivalent to freezer temperature.